Industry Briefs: Apr. 9, 2012 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Briefs: Apr. 9, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

American Regent has initiated a nationwide voluntary recall of cyanocobalamin injection, USP, 1000 mcg/mL, 1-mL vial, for the following lot numbers: 1662, 1679, and 1683, due to cracks in the vials. Read More

AnaptysBio has announced a partnership with Celgene to develop antibodies against multiple therapeutic targets. Read More

Haupt Pharma has launched cold-chain storage capabilities in Japan. Read More

MPI Research and has agreed to provide preclinical and clinical testing to Edge Therapeutics. Read More

Shimadzu Scientific Instruments and the University of Texas at Arlington have formed the Shimadzu Center for Advanced Analytical Chemistry. Read More

Spectrum Pharmaceuticals has agreed to acquire Allos Therapeutics. Read More

Univar has expanded its relationship with BASF Pharma by adding its Cognis Pharmaline range to its European pharmaceutical portfolio. Read More

People News

Bioanalytical Systems, Inc. (BASi) has named Jacqueline Lemke chief financial officer. Read More

Lonza has appointed Richard Ridinger as CEO. Read More


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here